PharmaLegacy
Latest round
- Series A
Last raised
- Feb 2019
Total raised
- Undisclosed
Investors
- 3
About PharmaLegacy
Based in Shanghai and established in 2008, PharmaLegacy is an comprehensive pre-clinical biomedical research and development service company that focuses on providing conforming country international standard pharmacological pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology and three types of medical device evaluation research services. It has 10000 square meter laboratory,of which 4000 square meter is animal vivarium that is accredited by AAALAC and house 10,000 rodents and large animals, and on-site capacity for up to 350 non-human primates. In February 2025, Shanghai OPM Biosciences announced to fully acquire PharmaLegacy. The company provides complete preclinical pharmacology services for early proof-of-concept of therapeutics and fulfillment of regulatory requirements. Specific services include oncology platform, non-human primates platform, inflammation and autoimmune diseases model, bone and orthopedics, respiratory diseases model, histopathology, metabolic and liver and cardiovascular diseases model. The company generates revenue by providing preclinical pharmacology services.
Who invested in PharmaLegacy
3 investors across 2 rounds
See all investors in PharmaLegacy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PharmaLegacy
Who invested in PharmaLegacy?
PharmaLegacy has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PharmaLegacy raised?
PharmaLegacy has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PharmaLegacy last raise money?
PharmaLegacy's most recent round on record is a Series A, in Feb 2019.
What does PharmaLegacy do?
Based in Shanghai and established in 2008, PharmaLegacy is an comprehensive pre-clinical biomedical research and development service company that focuses on providing conforming country international standard pharmacological pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology and three types of medical device evaluation research services.
Where is PharmaLegacy headquartered?
PharmaLegacy is headquartered in Shanghai, China.
Which VCs invest in companies like PharmaLegacy?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at PharmaLegacy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PharmaLegacy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.